Sweaty Betty reported an increase in turnover of 4.5% to £146.72 million in the 53 week to 3 January 2026, although earnings declined as higher administrative and operational costs associated with restructuring weighed on profitability.
What happened
Sweaty Betty reported an increase in turnover of 4.5% to £146.72 million in the 53 weeks to 3 January 2026, although earnings declined as higher administrative and operational costs associated with restructuring weighed on profitability.
Why it matters
UK turnover reached £111.14 million, accounting for 76% of total sales, down from 80% in the previous period. Rest-of-world turnover increased to £26.13 million from £20 million, representing 18% of sales. The US contributed £9.45 million, or 6% of turnover.
Yet the sportswear brand's increase in turnover is partly due to an extended reporting period. Sweaty Betty's latest accounts cover 53 weeks to 3 January 2026, compared with 52 weeks to 29 December 2024. Turnover increased by £6.3 million over the last reporting period, with £3.7 million of that rise coming from the additional week.
The company said that 2025 was a year of strategic implementation for Sweaty Betty, with the business focused on growing sales, streamlining stores, strengthening its digital channels and building customer loyalty.
This news brief is based on reporting published by TheIndustry.fashion on 2026-10-07. The original report is linked below.
TheIndustry.fashion
https://www.theindustry.fashion/sweaty-betty-sales-rise-4-5-but-restructuring-costs-hit-profitability/This independent news brief is based on the public source identified above. It is an original summary or translation, not a reproduction of the source article. Rights in source text, research, trademarks and images remain with their respective owners; images are used under the licence or permission identified in the credit. Rights holders may contact rights@goodproductasia.com with evidence of ownership. Verified concerns will be corrected, replaced or removed promptly. This report is not investment, legal, medical or purchasing advice.








